Dr Ireena Dutta

Name:	Dr Ireena Dutta
Affiliation:
E-mail:	(only provided to users who are logged into talks.cam)
Last login:	16 Oct 2014, 10:02 a.m.

Public lists managed by Dr Ireena Dutta

• Cancer Metabolism Interest Group Seminars
• DNA, Cells and Cancer- A Symposium to Honour Professor Ron Laskey
• Hutchison/MRC Research Centre Seminars
• Lister Institute Research Prize Fellowship Talks
• MRC Cancer Unit Seminars
• Women in Science

Talks given by Dr Ireena Dutta

Obviously this only lists talks that are listed through talks.cam. Furthermore, this facility only works if the speaker's e-mail was specified in a talk. Most talks have not done this.

Talks organised by Dr Ireena Dutta

This list is based on what was entered into the 'organiser' field in a talk. It may not mean that Dr Ireena Dutta actually organised the talk, they may have been responsible only for entering the talk into the talks.cam system.

• In vivo function-based genomic approaches for cancer drug target discovery
• Cell fate in response to anti-mitotic chemotherapeutics
• Title to be confirmed
• The role of stem cells in the pathogenesis of hepato-biliary cancers
• Title to be confirmed
• The Hippo Tumor Suppressor Network: Identifying New Therapeutic Targets
• Undermining Myc: Mitochondria Hold the Key
• Spatio-temporal control of RhoGTPases and the cytoskeleton in invading cancer cells by integrins and endocytic trafficking
• Targeting bioenergetics in hypoxic and rapidly growing tumours
• Cell death and autophagy in response to inhibition of glycolysis
• Molecular DNA Devices in Living Systems
• Translating Tumour Metabolism into New Diagnostics and Novel Anti-Cancer Therapeutics
• Chasing metabolic alterations in cancer
• Competition between adaptor protein and phospholipase regulates metastatic outcome
• The autophagy signaling network in the coordination of a cell's response
• Title to be confirmed
• The p53 pathway: 21 years of the "guardian of the genome"
• Insights for the role of tumour-related inflammation and stem cells in Drosophila
• Asian Cancer Genomics and its Clinical Implications
• Regulation of p53-dependent gene expression in vivo
• CD66+/Notch high cells in human cervical tumours: linking papillomavirus life cycle to cancer progression
• Genetic modifiers and microenvironmental control of tumor invasiveness
• Control of cytokinesis and the dark side of actomyosin forces
• Stem cell dynamics in the pancreas
• The Role of Glucose and Lipid Metabolism in Growth and Survival of Cancer Cells
• Macrophages Into Tumor Hypoxic Areas: Should I Stay Or Should I Go?
• Oncogenes and Tumour Metabolism
• Deciphering mechanisms regulating cell growth and homeostasis with genome-scale in silico models
• Warburg caught in a TRAP? The mitochondrial chaperone TRAP1 and neoplastic transformation
• Deconstructing Metastasis - Epigenetic Expansion of the VHL-HIF Signal Output Drives Renal Cancer Progression
• Exploiting cancer stem cells for the identification of mediators involved in brain tumorigenesis
• The NCI anticancer drug screen: Cancer through the lens of 60 cell lines
• Mitochondrial oxidative signaling in T cell activation: role for Warburg effect and a new ADP-dependent glucokinase
• Hypoxia and metabolism in cancer
• What is the epigenetic landscape of the vertebrate kinetochore?
• Telomeres and the challenges to chromosome integrity
• Dual role of BubR1 acetylation: Lessons from the acetylation-deficient mice
• Lactate in cancer: from waste glycolytic end-product to tumor growth-promoting factor
• Localisation-based feedback controls during mitosis and the maintenance of chromosomal stability
• Signalling Networks in Cell Proliferation and Fate Control
• Mutant p53 Enhances Receptor Recycling to Promote Invasion and Metastasis
• Glutamine Metabolism and mTOR Signaling in Cell Growth Regulation
• RNA Regulatory Networks Help Propagate the Effects of Genetic Alterations
• Epigenetic Regulatory Complexes in Development and Cancer
• The metabolism of hereditary renal cancer
• Aggressive breast tumors show altered lipid metabolism
• Metaplasia and carcinogenesis in stratified epithelia: the role of chronic inflammation
• Investigating key effectors downstream of APC (adenomatous polyposis coli) deletion in vivo
• Always on guard: p53 dynamics in single living cells
• Centrosome Amplification: Cancer’s Friend or Foe?
• Transcriptional control of EMT and malignant tumor progression
• Nischarin, a novel tumor suppressor of breast cancer
• Nischarin, a novel tumor suppressor of breast cancer
• Integration of Cell Growth and Cell Metabolism by Myc
• From gene regulation to cancer - arginine methylation makes its mark
• Modeling Minimal Residual Disease and Acquired Cancer Drug Resistance in vitro
• Pyruvate kinase M2 and cancer metabolism
• Mechanisms and regulation of centrosome biogenesis
• RB collaborators in cancer
• The story of the intracellular recycling factory- mTOR autophagy spatial coupling compartment (TASCC) augments secretory phenotypes
• Cancer Gene Discovery in the Mouse
• Metabolic synthetic lethality as a new strategy for cancer therapy
• Tumour-stroma Interactions in Breast Cancer
• Haploid Genetic Screens in Human Cells
• The ATM-mediated DNA damage response: moving between the forest and the trees
• CANCELLED
• Application of Systems Biology Approaches to Study Cell Signalling and Transcription
• Neuroblastoma- Disordered Developmental Programs Contribute to Tumorigenesis
• Expression of pluripotency factors in lung cancer – new opportunities for therapy?
• Myc inhibition has a dramatic therapeutic impact in diverse mouse models of cancer
• p53-based cancer therapy: potential & limitations
• Title to be confirmed
• Title to be confirmed
• The role of CCL21 in the development of lymphoid-like stroma and immunological tolerance in tumors
• An Achilles heel of oncogenic beta-catenin revealed through small molecule inhibition of its interaction with BCL9
• The pro-oncogenic role of Notch signaling in human epithelial cancer stem-like cells
• Molecular mechanisms that link inflammation and cancer
• Unravelling cancer cell signalling networks and screening for novel drug targets
• Dynamic Notch signaling in neural progenitor cells
• Title to be confirmed
• Mechanisms regulating neural differentiation
• Title to be confirmed
• The Role of the Receptor Tyrosine Kinase Antagonist, Lrig1, in Normal Tissue Homeostasis and Cancer
• Title to be confirmed
• Can we age in utero? Can we kill cancer cells by making them replicate faster? And other ATR stories…
• Cellular senescence: molecular mechanisms and implications for cancer and aging
• The irreversibility of cell cycle transitions: why the clock never turns back
• Molecular Mechanisms of Cellular Senescence in Cancer and Ageing
• Title to be confirmed
• BubR1 acetylation: a molecular switch modulating APC/C activity
• Role of biomarkers to guide prognosis and therapy of oesophageal adenocarcinoma
• Dissecting the mechanisms of microtubule-based cargo transport in vivo and in vitro
• A model for all genomes: the role of RNA polymerases fixed in factories
• Taming the tiger by the tail: modulation of DNA damage responses by telomeres
• Connecting Lung Epithelial Stem Cells and Lung Cancer by Stress-Activated Protein Kinases
• The spatial organisation of Ras signaling
• Role of the c-Myc-target gene Misu (NSun2) in regulating epidermal stem cell fate and its implications for cancer
• Patterns of stem and progenitor cell fate in adult tissues
• Title to be confirmed
• Delineating the Fanconi Anaemia DNA repair defect
• Title to be confirmed
• The ATM-Mediated DNA Damage Response- CANCELLED
• Chromatin modifying enzymes: their function and role in cancer